drugset / Trial / NCT03583931

Treatment of Complicated Parapneumonic Effusion With Fibrinolytic Therapy Versus VATs Decortication

NCT03583931

Completed 10 enrolled Denver Health and Hospital Authority
RandomizedParallel-groupOpen-labelTreatment

Summary

This study aims to standardize the treatment of pleural space (parapneumonic) infections by comparing the difference in outcomes between 2 methods of treatment: early VATS (Video Assisted Thorascopic Surgery) decortication versus fibrinolytic therapy. During treatment, the patient's coagulopathy status will also be evaluated.

Timeline

Start
2018-07-26
Primary completion
2020-02-02
Completion
2020-02-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alteplase Protein / enzyme biologic 10 mg Other
Comparator Streptokinase Protein / enzyme biologic 5 mg